Stockreport

Dermira up 3% premarket on start of late-stage development of lebrikizumab [Seeking Alpha]

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com
PDF Dermira up 3% premarket on start of late-stage development of lebrikizumab Dosing is underway DERM The late-stage program will include another identical Phase 3. Total e [Read more]